Most of the patients of our study were in stage B and stage C. The BCLC staging was determined according to the patients' albumin, bilirubin, ascites, encephalopathy, imaging reports, tumor size, portal vein invasion, tumor site, Child-Pugh score, and prothrombin activity. This evidence concerns the gene F2 and Ascites.